New search Hide text from Guidelines
C CARDIOVASCULAR SYSTEMC10 LIPID MODIFYING AGENTS
The DDDs are based on the treatment of hypercholesterolemia. |
C10A LIPID MODIFYING AGENTS, PLAIN
Pantethine, which is also used in the treatment of hyperlipidemi, is classified as a vitamin in A11HA.
C10AX Other lipid modifying agents
This group comprises all cholesterol and triglyceride reducers, which cannot be classified in the preceding groups.
Icosapent ethyl is classified in C10AX06 - omega-3-triglycerides incl. other esters and acids.
Sulodexide is classified in B01AB.
The DDD for evolocumab is based on dosing every second week. |
ATC code | Name | DDD | U | Adm.R | Note |
C10AX03 | tiadenol |
Last updated: 2020-12-17